DK145676C - Analogifremgangsmaade til fremstilling af oxoalkyldialkylxanthiner - Google Patents

Analogifremgangsmaade til fremstilling af oxoalkyldialkylxanthiner

Info

Publication number
DK145676C
DK145676C DK321574A DK321574A DK145676C DK 145676 C DK145676 C DK 145676C DK 321574 A DK321574 A DK 321574A DK 321574 A DK321574 A DK 321574A DK 145676 C DK145676 C DK 145676C
Authority
DK
Denmark
Prior art keywords
choydialychylxanthines
oxoal
preparation
analogy procedure
analogy
Prior art date
Application number
DK321574A
Other languages
Danish (da)
English (en)
Other versions
DK321574A (sv
DK145676B (da
Inventor
Werner Mohler
Manfred Jayme
Jaromir Komarek
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK321574A publication Critical patent/DK321574A/da
Publication of DK145676B publication Critical patent/DK145676B/da
Application granted granted Critical
Publication of DK145676C publication Critical patent/DK145676C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
DK321574A 1973-06-16 1974-06-14 Analogifremgangsmaade til fremstilling af oxoalkyldialkylxanthiner DK145676C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2330742A DE2330742C2 (de) 1973-06-16 1973-06-16 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2330742 1973-06-16

Publications (3)

Publication Number Publication Date
DK321574A DK321574A (sv) 1975-02-10
DK145676B DK145676B (da) 1983-01-24
DK145676C true DK145676C (da) 1983-08-01

Family

ID=5884209

Family Applications (1)

Application Number Title Priority Date Filing Date
DK321574A DK145676C (da) 1973-06-16 1974-06-14 Analogifremgangsmaade til fremstilling af oxoalkyldialkylxanthiner

Country Status (17)

Country Link
US (1) US4289776A (sv)
JP (1) JPS5233120B2 (sv)
AR (3) AR208179A1 (sv)
AT (1) AT334388B (sv)
BE (1) BE816332A (sv)
CH (2) CH612969A5 (sv)
DE (1) DE2330742C2 (sv)
DK (1) DK145676C (sv)
ES (1) ES427171A1 (sv)
FI (1) FI58920C (sv)
FR (1) FR2233065B1 (sv)
GB (1) GB1470220A (sv)
IE (1) IE39898B1 (sv)
NL (1) NL182806C (sv)
NO (1) NO140300C (sv)
SE (1) SE423631B (sv)
ZA (1) ZA743760B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (sv) * 1974-01-22 1978-12-29 Wuelfing J A Fa
DE2507555A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DE2507554A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS54112893A (en) * 1978-02-21 1979-09-04 Kohjin Co Ltd Preparation of 1-(5'-oxohexyl)-3,7-diethylxanthine
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
EP0042706B1 (en) * 1980-06-21 1985-12-27 BEECHAM - WUELFING GmbH & Co. KG Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
IT1197516B (it) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
DE3942872A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
EP0514789B1 (de) * 1991-05-23 1996-09-11 Hoechst Aktiengesellschaft Die Verwendung von 1-(5-Oxohexyl)-3-methyl-7-n-propyl-xanthin in der Gefässchirurgie
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
JP2549480B2 (ja) * 1991-12-10 1996-10-30 ヘキストジャパン株式会社 排尿障害改善剤
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
US5670506A (en) * 1993-04-05 1997-09-23 Cell Therapeutics, Inc. Halogen, isothiocyanate or azide substituted xanthines
AU1868195A (en) * 1994-01-28 1995-08-15 Cell Therapeutics, Inc. Cell signaling inhibitors
US5762953A (en) * 1996-08-22 1998-06-09 Theratech, Inc. Transdermal propentofylline compositions for the treatment of Alzheimers disease
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US20040110776A1 (en) * 2002-02-22 2004-06-10 Iok-Hou Pang Use of propentofylline to control intraocular pressure
JP5567503B2 (ja) 2008-02-29 2014-08-06 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US8952016B2 (en) 2009-02-27 2015-02-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
EP3397640B1 (en) * 2015-12-29 2021-08-04 INSERM - Institut National de la Santé et de la Recherche Médicale Xanthine derivative inhibitors of bet proteins
CN112724160A (zh) * 2021-03-19 2021-04-30 赤峰经方医药技术开发有限责任公司 一种己酮可可碱杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH325292A (de) * 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
DE1233405B (de) 1964-09-05 1967-02-02 Albert Ag Chem Werke Verfahren zur Herstellung von 7-(Oxoalkyl)-1, 3-dimethylxanthinen
US3737433A (en) 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
US3422107A (en) 1964-09-05 1969-01-14 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines and a process for the preparation thereof
DE1545689C2 (de) 1964-09-05 1982-07-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 2-Methyl-3-carbäthoxy-5,6-dihydropyran
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1810705C3 (de) * 1968-11-25 1980-11-27 Hoechst Ag, 6000 Frankfurt Stabilisierung von Vitaminen
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen

Also Published As

Publication number Publication date
JPS5047992A (sv) 1975-04-28
ZA743760B (en) 1975-06-25
NL182806C (nl) 1988-05-16
NO140300B (no) 1979-04-30
AT334388B (de) 1976-01-10
NO140300C (no) 1979-08-08
ES427171A1 (es) 1976-07-16
FI58920B (fi) 1981-01-30
FI181974A (sv) 1974-12-17
NO742121L (sv) 1975-01-13
AR209320A1 (es) 1977-04-15
DE2330742C2 (de) 1982-07-29
FR2233065B1 (sv) 1978-07-21
BE816332A (fr) 1974-12-16
JPS5233120B2 (sv) 1977-08-26
AR208179A1 (es) 1976-12-09
CH608807A5 (sv) 1979-01-31
DK321574A (sv) 1975-02-10
IE39898B1 (en) 1979-01-31
NL7407890A (sv) 1974-12-18
AU7014774A (en) 1975-12-18
FI58920C (fi) 1981-05-11
NL182806B (nl) 1987-12-16
ATA491874A (de) 1976-05-15
AR209319A1 (es) 1977-04-15
SE423631B (sv) 1982-05-17
DE2330742A1 (de) 1975-01-09
IE39898L (en) 1974-12-16
FR2233065A1 (sv) 1975-01-10
US4289776A (en) 1981-09-15
SE7407913L (sv) 1974-12-17
CH612969A5 (sv) 1979-08-31
GB1470220A (en) 1977-04-14
DK145676B (da) 1983-01-24

Similar Documents

Publication Publication Date Title
DK145676C (da) Analogifremgangsmaade til fremstilling af oxoalkyldialkylxanthiner
DK152050C (da) Analogifremgangsmaade til fremstilling af oxazolopyridiner
DK145157C (da) Analogifremgangsmaade til fremstilling af penicilliner
DK155043C (da) Analogifremgangsmaade til fremstilling af polyenforbindelser
DK144160C (da) Analogifremgangsmaade til fremstilling af 8-thiomethylergoliner
DK156642C (da) Analogifremgangsmaade til fremstilling af napthalenderivater
DK143902C (da) Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater
DK147004C (da) Analogifremgangsmaade til fremstilling af oxygenerede alkylxanthinderivater
DK132892C (da) Analogifremgangsmade til fremstilling af 4-aminoquinazoliner
DK145878C (da) Analogifremgangsmaade til fremstilling af alkylthiocyclopentanderivater
DK142455C (da) Analogifremgangsmaade til fremstilling af thiaprostaglandiner
DK155314C (da) Fremgangsmaade til fremstilling af xylitol
DK146539C (da) Analogifremgangsmaade til fremstilling af 7alfa-methoxycephalosporin-derivater
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
DK155316C (da) Analogifremgangsmaade til fremstilling af omega-nor-cycloalkyl-13,14-dehydroprostaglandiner
DK144270C (da) Analogifremgangsmaade til fremstilling af n-carbamoyl-2-phenylethensulfonamider
DK145179C (da) Analogifremgangsmaade til fremstilling af aryloxyalkyl-forbindelser
DK137924C (da) Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner
DK133950C (da) Fremgangsmade til fremstilling af halogenholdige tertiere phosphinoxider
DK131943C (da) Fremgangsmade til fremstilling af 17beta-oxalylsteroider
DK143027C (da) Analogifremgangsmaade til fremstilling af isoxazolderivater
DK133303C (da) Analogifremgangsmade til fremstilling af digitoxinorthoformiater
DK144065C (da) Analogifremgangsmaade til fremstilling af thiazolderivater
DK133777C (da) Fremgangsmade til fremstilling af alfa-oximinonitriler
DK135580C (da) Fremgangsmade til fremstilling af bis-halogencarbonylaniliner